Business Daily from THE HINDU group of publications
Thursday, April 3, 2008 ePaper | Mobile/PDA Version
|
Business Daily from THE HINDU group of publications Thursday, April 3, 2008 ePaper | Mobile/PDA Version |
|
|
|
|
|
|
||
|
News Update as at 18.00 hrs (IST)
Corporate Ranbaxy launches bio-generic injectable for osteoporosis MUMBAI: Country's largest drug maker Ranbaxy Laboratories Ltd on Thursday announced the launch of 'Bonisa - teriparatide' injection used in the treatment of osteoporosis disease in collaboration with Hyderabad-based Virchow Biotech Pvt Ltd. Bonista-teriparatide injection is manufactured by recombinant human parathyroid hormone and Ranbaxy has become first company in the world to launch this bio generic product, the company said in a filing to the Bombay Stock Exchange. The product has been indigenously researched at 'Virchow Biotech and developed with aid from the Department of Science and Technology under the Indian Government. "Bonista is also a classic example of our endeavours to offer quality bio-generic therapeutic options to doctors and an affordable and efficacious product to patients,'' Ranbaxy Senior Vice President & Regional Director (Asia & CIS) Sanjeev I Dani said. - PTI
Prev: Leighton bags coal mine project in India Business Line | NUS Index | |
Related Topics Alliances & Joint Ventures Announcements Auditing Awards & Honours Bonus Announcements Company Law Corporate Bonds Corporate Disputes Corporate Governance Courts/Legal Issues Diversification Environment Human Resources Interview IPOs IPR Management Mergers & Acquisitions New Projects Open Offers Outlook Outsourcing Overseas Borrowings Overseas Investments People Performance Preferential Allotments Private Placement Regulatory Bodies & Rulings Research & Development Restructuring Rights Issue Sick Units Society & Development Standards & Benchmarks Taxation Trade & Labour Unions |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line
|